{"id":"https://openalex.org/W2076198515","doi":"https://doi.org/10.1080/10673220490905688","title":"Office-Based Buprenorphine Treatment for Opioid-Dependent Patients","display_name":"Office-Based Buprenorphine Treatment for Opioid-Dependent Patients","alternate_titles":[],"publication_year":2004,"publication_date":"2004-11-01","ids":{"openalex":"https://openalex.org/W2076198515","doi":"https://doi.org/10.1080/10673220490905688","mag":"2076198515","pmid":"https://pubmed.ncbi.nlm.nih.gov/15764468"},"language":"en","primary_location":{"id":"doi:10.1080/10673220490905688","doi":"https://doi.org/10.1080/10673220490905688","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10673220490905688","pdf_url":null,"source":{"id":"https://openalex.org/S7919625","display_name":"Harvard Review of Psychiatry","issn_l":"1067-3229","issn":["1067-3229","1465-7309"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Harvard Review of Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2076198515"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072635409","display_name":"Elinore F. McCance\u2010Katz","orcid":"https://orcid.org/0000-0002-4296-7012","observed_orcids":["https://orcid.org/0000-0002-4296-7012"]},"institutions":[{"id":"https://openalex.org/I184840846","display_name":"Virginia Commonwealth University","ror":"https://ror.org/02nkdxk79","country_code":"US","type":"education","lineage":["https://openalex.org/I184840846"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Elinore F. McCance-Katz","raw_affiliation_strings":["Division of Addiction Psychiatry, Department of Psychiatry, Virginia Commonwealth University, VA, USA. emccancekatz@vcu.edu","From the Division of Addiction Psychiatry Department of Psychiatry Virginia Commonwealth University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Addiction Psychiatry, Department of Psychiatry, Virginia Commonwealth University, VA, USA. emccancekatz@vcu.edu","institution_ids":["https://openalex.org/I184840846"]},{"raw_affiliation_string":"From the Division of Addiction Psychiatry Department of Psychiatry Virginia Commonwealth University","institution_ids":["https://openalex.org/I184840846"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5072635409"],"corresponding_institution_ids":["https://openalex.org/I184840846"],"apc_list":null,"apc_paid":null,"fwci":0.3838,"has_fulltext":false,"cited_by_count":53,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.37511191,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"12","issue":"6","first_page":"321","last_page":"338"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9869999885559082},{"id":"https://openalex.org/keywords/opioid-use-disorder-treatment","display_name":"opioid use disorder treatment","score":0.7429999709129333},{"id":"https://openalex.org/keywords/office-based-treatment","display_name":"office-based treatment","score":0.6499999761581421},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.5220000147819519},{"id":"https://openalex.org/keywords/naloxone","display_name":"naloxone","score":0.8410000205039978},{"id":"https://openalex.org/keywords/prescription-drug-misuse","display_name":"prescription drug misuse","score":0.6919999718666077},{"id":"https://openalex.org/keywords/heroin-dependence","display_name":"heroin addiction","score":0.8999999761581421},{"id":"https://openalex.org/keywords/clinical-pharmacology","display_name":"clinical pharmacology","score":0.8190000057220459},{"id":"https://openalex.org/keywords/special-populations","display_name":"special populations","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.9588885307312012},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6341473460197449},{"id":"https://openalex.org/C2910878864","wikidata":"https://www.wikidata.org/wiki/Q908096","display_name":"Narcotic antagonists","level":5,"score":0.6069760918617249},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5930542349815369},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4523625075817108},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.41533994674682617},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.36114799976348877},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15703418850898743},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.15574076771736145},{"id":"https://openalex.org/C2778750930","wikidata":"https://www.wikidata.org/wiki/Q4540629","display_name":"(+)-Naloxone","level":4,"score":0.1286211907863617},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000553","descriptor_name":"Ambulatory Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/10673220490905688","doi":"https://doi.org/10.1080/10673220490905688","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10673220490905688","pdf_url":null,"source":{"id":"https://openalex.org/S7919625","display_name":"Harvard Review of Psychiatry","issn_l":"1067-3229","issn":["1067-3229","1465-7309"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Harvard Review of Psychiatry","raw_type":"journal-article"},{"id":"pmid:15764468","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15764468","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Harvard review of psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2085589547","display_name":" Enhancing Health Care of Drug Users with HIV","funder_award_id":"K02DA000478","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G3025986535","display_name":null,"funder_award_id":"KO2 DA00478","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W88201490","https://openalex.org/W198825371","https://openalex.org/W1579393208","https://openalex.org/W1582299489","https://openalex.org/W1591518578","https://openalex.org/W1788979206","https://openalex.org/W1866103410","https://openalex.org/W1885486770","https://openalex.org/W1966282663","https://openalex.org/W1968731926","https://openalex.org/W1969202318","https://openalex.org/W1972490292","https://openalex.org/W1980561702","https://openalex.org/W1982394821","https://openalex.org/W1982786105","https://openalex.org/W1985379431","https://openalex.org/W1987122239","https://openalex.org/W1990071324","https://openalex.org/W1990905986","https://openalex.org/W1992389336","https://openalex.org/W1999228574","https://openalex.org/W2013122535","https://openalex.org/W2018914766","https://openalex.org/W2019939029","https://openalex.org/W2021026424","https://openalex.org/W2033312182","https://openalex.org/W2039946626","https://openalex.org/W2040457035","https://openalex.org/W2050443628","https://openalex.org/W2070037345","https://openalex.org/W2075416250","https://openalex.org/W2082052010","https://openalex.org/W2097506752","https://openalex.org/W2097910464","https://openalex.org/W2098684993","https://openalex.org/W2098843949","https://openalex.org/W2105540175","https://openalex.org/W2108978934","https://openalex.org/W2109905455","https://openalex.org/W2122130641","https://openalex.org/W2135199958","https://openalex.org/W2145139215","https://openalex.org/W2147528480","https://openalex.org/W2152591738","https://openalex.org/W2170134717","https://openalex.org/W2171737529","https://openalex.org/W4240267522"],"related_works":["https://openalex.org/W2270480675","https://openalex.org/W2072875315","https://openalex.org/W2014162774","https://openalex.org/W1967284091","https://openalex.org/W2164361529","https://openalex.org/W2027873427","https://openalex.org/W2014646112","https://openalex.org/W2000393144","https://openalex.org/W2006406451"],"abstract_inverted_index":{"Opioid":[0],"dependence":[1],"is":[2,34,54],"epidemic":[3],"in":[4,88,98],"the":[5,22,27,37,67],"United":[6],"States,":[7],"with":[8,81],"increasing":[9],"numbers":[10],"addicted":[11],"to":[12,26,30,83],"heroin":[13],"and":[14,53,93],"burgeoning":[15],"abuse":[16],"of":[17,41,90],"prescription":[18,57],"opioid":[19,32,38,75,91],"analgesics.":[20],"Buprenorphine,":[21],"most":[23],"recent":[24],"addition":[25],"pharmacotherapies":[28,39],"available":[29,55],"treat":[31],"dependence,":[33,92],"novel":[35],"among":[36],"because":[40],"its":[42,77,96],"partial":[43],"agonist":[44],"properties.":[45],"It":[46],"has":[47],"been":[48],"placed":[49],"on":[50],"Schedule":[51],"III":[52],"by":[56],"from":[58],"a":[59,72],"physician's":[60],"office-based":[61],"practice.":[62],"This":[63],"review":[64],"briefly":[65],"summarizes":[66],"research":[68],"supporting":[69],"buprenorphine":[70],"as":[71],"treatment":[73,89],"for":[74],"dependence--including":[76],"clinical":[78,86],"pharmacology,":[79],"formulation":[80],"naloxone":[82],"prevent":[84],"diversion,":[85],"use":[87,97],"issues":[94],"regarding":[95],"special":[99],"populations.":[100]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2076198515","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
